|
Market Closed -
Nasdaq
21:00:00 21/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.070 USD | +1.75% |
|
-13.95% | -72.65% |
| 08-13 | Seres Therapeutics Files $300 Million Mixed Shelf | MT |
| 08-05 | Seres Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.75% | -13.95% | -10.75% | -38.43% | -72.65% | -76.68% | -92.52% | -97.05% | -98.58% | 40.46M | |
| +4.98% | +5.73% | +3.13% | +63.51% | +85.30% | +54.45% | +113.83% | +10.21% | - | 74.33B | |
| -0.44% | +0.63% | 0.00% | +8.57% | +20.56% | +36.91% | +81.02% | +221.03% | +5,623.18% | 62.26B | |
| -0.66% | +6.97% | +8.33% | +71.28% | +67.46% | +31.36% | +23.45% | -56.31% | - | 27.72B | |
| +0.83% | -3.43% | -3.79% | +26.30% | -30.48% | -16.41% | +359.38% | +354.37% | +721.45% | 26.42B | |
| +2.02% | -0.87% | -15.93% | +7.82% | +2.94% | +1.85% | -7.92% | -71.29% | - | 24.62B | |
| -0.75% | +4.28% | +6.16% | +35.43% | +10.61% | +23.49% | -11.35% | -19.87% | +95.64% | 20.72B | |
| -2.54% | -3.36% | -17.86% | +20.35% | +171.42% | +149.64% | +324.48% | +1,371.57% | +639.24% | 15.01B | |
| -1.95% | +1.80% | +5.81% | +10.23% | +30.55% | +42.69% | +165.15% | +181.46% | +288.20% | 14.18B | |
| -5.32% | -8.25% | +28.42% | +22.91% | -3.37% | -10.53% | +823.50% | +160.80% | +116.67% | 13.48B | |
| -1.09% | +6.01% | -6.27% | +24.92% | +24.99% | -6.72% | +522.48% | - | - | 15.1B | |
| -1.80% | -3.35% | +1.01% | +3.21% | -10.37% | +18.65% | +227.23% | +565.43% | +4,585.46% | 12.06B | |
| -3.42% | +0.68% | +8.55% | +15.61% | -15.13% | -26.79% | +155.73% | +119.95% | - | 11.66B | |
| -1.77% | -6.75% | -12.08% | -14.24% | +6.33% | +38.84% | +116.26% | +105.54% | +663.39% | 9.39B | |
| +3.47% | -14.73% | -21.03% | -15.93% | +3.62% | +124.14% | +152.63% | +10.31% | +854.09% | 9.72B | |
| -0.35% | +0.96% | +8.47% | +14.81% | +326.77% | +209.52% | +416.82% | -14.73% | - | 8.96B | |
| +1.36% | -1.04% | -5.91% | +14.54% | +27.70% | +85.57% | +12.90% | +133.16% | - | 8.77B | |
| -1.12% | +5.17% | +6.94% | +18.88% | +10.21% | -23.70% | +96.17% | -22.59% | - | 8.73B | |
| +1.97% | +1.35% | -13.58% | +4.18% | +180.92% | +518.48% | +688.60% | -52.19% | -42.21% | 8.11B | |
| +1.43% | +0.23% | +7.66% | +18.67% | +8.40% | +147.01% | +493.84% | - | - | 6.98B | |
| Average | +0.14% | -0.92% | -1.14% | +15.63% | +42.29% | +66.09% | +233.08% | +161.10% | +1,222.41% | 18.91B | |
| Weighted average by Cap. | +0.78% | +1.41% | +0.06% | +27.78% | +44.66% | +50.38% | +185.78% | +154.99% | +2,381.84% |
- Stock Market
- Stocks
- MCRB Stock
- Sector Seres Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
